Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119824) titled 'A retrospective observational study of irinotecan liposome in patients with advanced gastrointestinal cancer and its correlation with adverse reactions' on March 4.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Shanghai General Hospital
Condition:
Patients with advanced gastrointestinal cancer
Intervention:
Pancreatic cancer group:N
Colorectal cancer group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-06
Target Sample Size: Pancreatic cancer group:50;Colorectal cancer group:50;Gallbladder cancer group:50;
Countries of Recruit...